Display options
Share it on

PLoS Negl Trop Dis. 2021 Sep 23;15(9):e0009794. doi: 10.1371/journal.pntd.0009794. eCollection 2021 Sep.

Assessment of neuropathic pain in leprosy patients with relapse or treatment failure by infrared thermography: A cross-sectional study.

PLoS neglected tropical diseases

Liliane Marques de Pinho Tiago, Diogo Fernandes Dos Santos, Douglas Eulálio Antunes, Letícia Marques Pinho Tiago, Isabela Maria Bernardes Goulart

Affiliations

  1. National Reference Center for Sanitary Dermatology and Leprosy, Clinical Hospital, Federal University of Uberlandia, Uberlândia, Brazil.
  2. Graduate Program in Health Sciences, Faculty of Medicine, Federal University of Uberlandia, Uberlândia, Brazil.
  3. Graduate Program in biomedical engineering, Faculty of Electrical Engineering, Federal University of Uberlandia, Uberlândia, Brazil.

PMID: 34555035 PMCID: PMC8491942 DOI: 10.1371/journal.pntd.0009794

Abstract

BACKGROUND: Neuropathic pain (NP) is one of the main complications of leprosy, and its management is challenging. Infrared thermography (IRT) has been shown to be effective in the evaluation of peripheral autonomic function resulting from microcirculation flow changes in painful syndromes. This study used IRT to map the skin temperature on the hands and feet of leprosy patients with NP.

METHODOLOGY/PRINCIPAL FINDINGS: This cross-sectional study included 20 controls and 55 leprosy patients, distributed into 29 with NP (PWP) and 26 without NP (PNP). Thermal images of the hands and feet were captured with infrared camera and clinical evaluations were performed. Electroneuromyography (ENMG) was used as a complementary neurological exam. Instruments used for the NP diagnosis were visual analog pain scale (VAS), Douleur Neuropathic en 4 questions (DN4), and simplified neurological assessment protocol. The prevalence of NP was 52.7%. Pain intensity showed that 93.1% of patients with NP had moderate/severe pain. The most frequent DN4 items in individuals with NP were numbness (86.2%), tingling (86.2%) and electric shocks (82.7%). Reactional episodes type 1 were statistically significant in the PWP group. Approximately 81.3% of patients showed a predominance of multiple mononeuropathy in ENMG, 79.6% had sensory loss, and 81.4% showed some degree of disability. The average temperature in the patients' hands and feet was slightly lower than in the controls, but without a significant difference. Compared to controls, all patients showed significant temperature asymmetry in almost all points assessed on the hands, except for two palmar points and one dorsal point. In the feet, there was significant asymmetry in all points, indicating a greater involvement of the lower limbs.

CONCLUSION: IRT confirmed the asymmetric pattern of leprosy neuropathy, indicating a change in the function of the autonomic nervous system, and proving to be a useful method in the approach of pain.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

  1. Int J Lepr Other Mycobact Dis. 2004 Jun;72(2):134-8 - PubMed
  2. J Med Eng Technol. 2005 Nov-Dec;29(6):257-67 - PubMed
  3. PLoS Negl Trop Dis. 2017 Nov 27;11(11):e0006086 - PubMed
  4. Neurol Clin Pract. 2019 Dec;9(6):468-471 - PubMed
  5. Muscle Nerve. 2004 Oct;30(4):393-409 - PubMed
  6. Physiol Meas. 2012 Mar;33(3):R33-46 - PubMed
  7. Rev Soc Bras Med Trop. 2009 Jul-Aug;42(4):420-4 - PubMed
  8. Skeletal Radiol. 1984;12(4):235-49 - PubMed
  9. Pain Rep. 2019 Dec 06;4(6):e743 - PubMed
  10. Reumatologia. 2017;55(1):38-43 - PubMed
  11. Mayo Clin Proc. 2003 May;78(5):603-12 - PubMed
  12. Surg Clin North Am. 1999 Apr;79(2):231-52 - PubMed
  13. J Neurosurg. 1985 May;62(5):716-20 - PubMed
  14. Lancet Neurol. 2010 Aug;9(8):807-19 - PubMed
  15. PLoS Negl Trop Dis. 2011 Mar 08;5(3):e981 - PubMed
  16. Pathog Glob Health. 2014 Jun;108(4):186-90 - PubMed
  17. Infect Dis Poverty. 2017 Sep 1;6(1):115 - PubMed
  18. Rev Neurol (Paris). 2019 Jan - Feb;175(1-2):16-25 - PubMed
  19. Pain Rep. 2018 Feb 23;3(2):e638 - PubMed
  20. Pain. 2012 Aug;153(8):1620-1624 - PubMed
  21. BMC Infect Dis. 2019 May 22;19(1):460 - PubMed
  22. Arq Neuropsiquiatr. 2013 Sep;71(9B):661-6 - PubMed
  23. Lepr Rev. 2007 Dec;78(4):369-80 - PubMed
  24. Lepr Rev. 2008 Sep;79(3):270-6 - PubMed
  25. PLoS Negl Trop Dis. 2017 Feb 13;11(2):e0005364 - PubMed
  26. Clin Dermatol. 2016 Jan-Feb;34(1):51-8 - PubMed
  27. Int J Lepr Other Mycobact Dis. 2004 Jun;72(2):166-8 - PubMed
  28. Biomed Eng Online. 2004 Jun 28;3(1):19 - PubMed
  29. Arq Neuropsiquiatr. 2021 Aug;79(8):716-723 - PubMed
  30. PLoS Negl Trop Dis. 2018 Jul 2;12(7):e0006610 - PubMed
  31. Br J Anaesth. 2017 Oct 1;119(4):765-774 - PubMed
  32. Pain. 2005 Mar;114(1-2):29-36 - PubMed
  33. Pain. 2019 Jan;160(1):88-94 - PubMed
  34. Biomed Eng Online. 2006 May 12;5:30 - PubMed
  35. Korean J Pain. 2013 Jul;26(3):219-22 - PubMed
  36. Rev Bras Epidemiol. 2014 Dec;17(4):899-910 - PubMed
  37. Am J Trop Med Hyg. 2018 Jun;98(6):1609-1613 - PubMed
  38. Lepr Rev. 2012 Jun;83(2):195-201 - PubMed
  39. Brain. 2010 Oct;133(10):2838-44 - PubMed
  40. J Pain. 2010 May;11(5):484-90 - PubMed
  41. Int Health. 2012 Jun;4(2):77-85 - PubMed
  42. Open Neurol J. 2015 Jun 26;9:24-7 - PubMed
  43. Clin Infect Dis. 2007 Jan 1;44(1):33-40 - PubMed

Publication Types